Irvine, Calif. – January 15, 2026 – Today, Johnson & Johnson announced the U.S. launch of the Arbrea Breast Simulator Surgeon App for Mentor, a digital consultation tool available on tablets and smart phones that helps plastic surgeons personalize planning for patients by visualizing potential outcomes during consultations.
“The Arbrea Breast Simulator Surgeon App for Mentor gives surgeons an easy-to use digital tool that helps transform their augmentation consultations into clear, patient-centered conversations,” said Alenka Brzulja, Worldwide President, Aesthetics & Reconstruction, MedTech, Johnson & Johnson. “Many women spend months or even years considering breast augmentation. By allowing them to visualize potential outcomes in seconds, this app brings clarity to the decision-making process, supports a more confident, personal choice, and has been shown to help patients feel ready to make decisions more quickly.”
Although patients considering breast augmentation increasingly rely on online research and social media to inform their decision-making process, consultations with plastic surgeons often remain largely analog. Most plastic surgeons still use physical sizers and before-and-after galleries to guide conversations about outcomes. The Arbrea Breast Simulator Surgeon App for Mentor delivers a personalized 3D simulation in about 60 seconds, enhancing clinical discussions in real time and helping patients visualize how different options could look on their own bodies.
“I’ve seen it many times in my practice. A patient comes in feeling excited and eager to explore their options, but when they’re unable to visualize the results on their own body, anxiety and uncertainty sets in and their enthusiasm can fade,” said Kriti Mohan, M.D., board-certified plastic surgeon based in Houston, Texas. “Patients want to feel confident in their decisions and also in their potential results. The Arbrea Breast Simulator Surgeon App for Mentor has given me a way to provide clear, personalized visualizations that help my patients better understand their anatomy and options so that they are able to move forward with their breast augmentation procedure with greater confidence.”
Recently published research in the Aesthetic Surgery Journal Open Forum underscores the need for solutions that help patients better visualize outcomes during breast augmentation consultations. The study found that while 68.4% of women surveyed had considered the procedure, only 17.5% had undergone it, and just 7.2% of those who consulted proceeded to surgery.1 Among the factors influencing decision making was concern about whether results would look natural, highlighting how uncertainty around aesthetic outcomes remains a key barrier to surgical decision making.
Two separate studies have demonstrated the positive impact of the Arbrea Breast Simulator App on the consultation experience. In one study, patients rated the app 3.4 out of 4 for how closely it matched their final surgical result.2 In another, clinics reported conversion rates as high as 87% for consultations using the app, demonstrating its role in helping patients visualize their desired results and feel more confident in moving forward with breast augmentation.3
The Arbrea Breast Simulator Surgeon App for Mentor is now available to plastic surgeons in the U.S. and will be showcased at major aesthetic surgery meetings throughout 2026. For more information, please visit our website.
About Aesthetics & Reconstruction
At Johnson & Johnson MedTech, we are redefining possibilities in breast aesthetics by delivering a comprehensive portfolio of science-based, evidence-backed solutions designed to help women enhance and restore their confidence and quality of life. As the #1 global brand, we take pride in being a trusted partner in breast augmentation and reconstruction for both consumers and healthcare professionals. In everything we do, we use a patient-first approach that encourages choice and personal empowerment. For more than 40 years, MENTOR™ products have been developed with this very goal in mind. Available in 118 countries, MENTOR™ Breast Implants have been chosen by over 9 million women worldwide.
About Surgical Solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world’s most complex and pervasive health challenges. For over 100 years, we have helped advance surgical care through our innovative portfolio across wound closure, adjunctive hemostats, surgical stapling and instruments, robotics and digital solutions. Together, with clinicians and healthcare experts around the world we are progressing what’s next in surgery to better solve patient needs in metabolic and cardiovascular disease, cancer, and aesthetics and reconstruction. For more, visit Breast Implants by Mentor, follow Mentor Worldwide, LLC on LinkedIn, Breast Implants by Mentor on Instagram and Breast Implants by Mentor on Facebook.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector’s global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn. Mentor Worldwide, LLC is part of Johnson & Johnson MedTech.
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 related to the U.S. launch of the Arbrea Breast Simulator Surgeon App for Mentor. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: competition, including technological advances, new products and patents attained by competitors; uncertainty of commercial success for new products; the ability of the company to successfully execute strategic plans; impact of business combinations and divestitures; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; and global health care reforms and trends toward health care cost containment.
A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s most recent Annual Report on Form 10-K, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com, www.investor.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.
Footnotes:
*Dr. Mohan is a paid consultant for Mentor Worldwide, LLC and Johnson & Johnson MedTech.
1. William P Adams, Francisco G Bravo, M Bradley Calobrace, Andre Cervantes, Caroline Glicksman, Craig Layt, Jie Luan, Lina Triana, Per Hedén, Drivers and Barriers of Breast Augmentation Surgery: Multinational Insights, Aesthetic Surgery Journal Open Forum, 2025;, ojaf117, https://doi.org/10.1093/asjof/ojaf117
2. La Padula S, Pensato R, D’Andrea F, de Gregorio L, Errico C, Rega U, Canta L, Pizza C, Roccaro G, Billon R, et al. Assessment of Patient Satisfaction Using a New Augmented Reality Simulation Software for Breast Augmentation: A Prospective Study. J Clin Med. 2022;11(12):3464. doi:10.3390/jcm11123464
3. Barbon C, Dibra E, Otte M. Pushing boundaries in aesthetic breast surgery: surgical planning based solely on online consultation and 3D simulation. Aesthetic Plast Surg. 2024;48(Suppl 1):S127. Abstract RF13.01. Presented at: ISAPS World Congress 2024; Cartagena, Colombia
US_MNT_AMNT_410886
© Johnson and Johnson and its affiliates 2026
Media Contact:
Lindsey Diaz-MacInnis
ldiazmac@its.jnj.com